I completely disagree with your assessment. They need to put the horse before the cart. They are already HANDSOMELY paid for their talent thus far. Now it’s time to protect the investors who are SOLEY carrying the risk of ZERO payout if CytoDyn officers and new hires can’t get an approval. I am particularly upset about this! A TOTAL NO VOTE from me until they have REVENUE PRODUCING news, not dilutionary news accelerating us to diminished returns..